MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
3.890
+0.030
+0.78%
Closed 17:59 03/27 EDT
OPEN
3.890
PREV CLOSE
3.860
HIGH
3.920
LOW
3.860
VOLUME
799.67K
TURNOVER
0
52 WEEK HIGH
7.00
52 WEEK LOW
3.295
MARKET CAP
223.82M
P/E (TTM)
89.22
1D
5D
1M
3M
1Y
5Y
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
Barchart · 14h ago
Weekly Report: what happened at VNDA last week (0318-0322)?
Weekly Report · 2d ago
Lisata's (LSTA) LSTA1 Gets FDA's RPDD Tag for Osteosarcoma
NASDAQ · 5d ago
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
NASDAQ · 6d ago
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
NASDAQ · 03/18 15:23
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
NASDAQ · 03/18 10:55
Weekly Report: what happened at VNDA last week (0311-0315)?
Weekly Report · 03/18 10:26
Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin
NASDAQ · 03/13 16:45
More
About VNDA
Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.